15, 16, D-CuP, ROS-responsive hydrogel matrix (G) and G/D-CuP demonstrated good biocompatibility
Thus, the purpose of this review is to discuss the structure, inactivation, and roles of p53 in diseases and therapeutic strategies targeting p53 in cancer and noncancer diseases
As fitness and pharma converge, new models are emerging
PlexusDx emphasizes precision-wellnessmatching treatment to both your surgical history and your genetic predispositions in peptide metabolism
En Continental Hospitals, combinamos experiencia, tratamientos avanzados y atencin personalizada
Study selection Two reviewers (KP and OR) independently screened all titles and abstracts, followed by full-text assessment of potentially eligible studies